News for November 2019

News Archive

Linking wound healing and cancer risk Linking wound healing and cancer risk

When our skin is damaged, a whole set of biological processes springs into action to heal the wound. Now, researchers from the VIB-UGent Center for Inflammation Research have shown that one of the molecules involved in this, HMGB1, slows down wound healing. It is, however, also essential for tumor formation at sites of previous injury. The researchers found that HMGB1 controls the actions of neutrophils, a specific type of immune cells, in skin wounds and that this is crucial for cancer initiation. Targeting this pathway could be beneficial in diabetic wound care and in patients suffering from skin blistering diseases. Their work appears in Cell Reports.

Novoheart to Co-develop First of its Kind Human Heart-in-a-Jar Model of Heart Failure with AstraZeneca Novoheart to Co-develop First of its Kind Human Heart-in-a-Jar Model of Heart Failure with AstraZeneca

Heart failure is a global pandemic with an estimated 64.3 million cases worldwide in 2017, costing over US$100B per year. Drug developers currently lack effective humanized models for preclinical testing of targeted drug candidates in heart failure with preserved ejection fraction. The collaboration aims to provide a unique solution for future assessment of novel therapeutics.

The Current issue of “The view from here” is concerned with Immunotherapies The Current issue of “The view from here” is concerned with Immunotherapies

The topic of this month’s newsletter from Drug Discovery Today is “Immunotherapies”.

Mogrify wins Seed Stage Finance Raise of the Year at 2019 European Lifestars Awards Mogrify wins Seed Stage Finance Raise of the Year at 2019 European Lifestars Awards

Celebrating success across life sciences

Breakthrough protein analysis instrument – the Fluidity One-W – launches at PEGS Europe 2019 Breakthrough protein analysis instrument – the Fluidity One-W – launches at PEGS Europe 2019

Accurate and detailed protein interactions analysis under near-native conditions with an easy-to-use system

EIT Health receives global recognition of impact and performance for its Accelerator programme EIT Health receives global recognition of impact and performance for its Accelerator programme

Results from the UBI Global World Benchmark Study 2019 denoting rankings of the best accelerators and incubators have been announced at the World Incubation Summit in Doha, Qatar.

International Survey Shows a Lack of Knowledge About Risk Factors Associated with Type 2 Diabetes International Survey Shows a Lack of Knowledge About Risk Factors Associated with Type 2 Diabetes

Results of the survey, initiated by Merck and conducted by YouGov, indicated that there is a need to better educate people on the risk factors of type 2 diabetes, which can be prevented. The representative survey included over 9,000 people across 9 countries

TTP plc Desktop Biology enables development and manufacture of DnaNudge technology TTP plc Desktop Biology enables development and manufacture of DnaNudge technology

Novel multiplex technology developed to help consumers make healthier choices based on their genetic profile. TTP involved with all aspects of product development, from initial concept to prototype testing and manufacture. Culmination of technology and product development partnership spanning just over 3 years

Thermo Scientific Aquilos 2 Cryo-FIB Speeds Sample Preparation

Latest DualBeam system provides significant clarity of protein interactions

RSSL Named Best CRO at OBN Awards RSSL Named Best CRO at OBN Awards

Outstanding dedication to quality, science and customer service helped Reading Scientific Services Ltd (RSSL) secure Best Contract Research Organisation (CRO) at this year’s Oxford Bioscience Network (OBN) Awards.

Engine I MHP appointed by global coalition to deliver innovative digital campaign to fight childhood pneumonia Engine I MHP appointed by global coalition to deliver innovative digital campaign to fight childhood pneumonia

Engine I MHP has been appointed as the preferred communications partner for Every Breath Counts, a global coalition of organisations with a mission to end preventable child pneumonia deaths by 2030.

Catalent Biologics Launches GPExR Boost Cell Line Expression Technology to Improve Titers and Cell-Specific Productivity Catalent Biologics Launches GPExR Boost Cell Line Expression Technology to Improve Titers and Cell-Specific Productivity

SOMERSET, N.J. – November 4, 2019 — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced the launch of its next-generation cell line development technology, GPEx® Boost.

Engitix Receives a Golden Ticket to LabCentral from Takeda to Advance Fibrosis and Solid Tumour Research Engitix Receives a Golden Ticket to LabCentral from Takeda to Advance Fibrosis and Solid Tumour Research

Golden Ticket includes one year of lab bench space at Cambridge, MA-based shared laboratory and office space

Nanoform wins the CPhI Excellence in Pharma Award for Formulation Nanoform wins the CPhI Excellence in Pharma Award for Formulation

Helsinki, Finland – Nanoform, an innovative medicine enabling nanotechnology company, has won the Excellence in Pharma Award for Formulation at the prestigious CPhI Pharma Awards. Receiving this highly contested prize is an acknowledgement of Nanoform’s commitment to innovation in the industry through its best-in-class CESS® nanonization™ technology.

Sphere Fluidics and Peak Analysis and Automation introduce integrated micro-plate handling and single cell analysis capabilities Sphere Fluidics and Peak Analysis and Automation introduce integrated micro-plate handling and single cell analysis capabilities

• Integration of PAA’s S-LAB with Sphere Fluidics’ Cyto-Mine Single Cell Analysis System increases throughput in antibody discovery and cell line development• Launch at ELRIG Drug Discovery 2019, 5–6 November, Liverpool

Repositive unveils molecular search functionality for its Cancer Models Platform at ELRIG Drug Discovery Repositive unveils molecular search functionality for its Cancer Models Platform at ELRIG Drug Discovery

This innovative new feature will further support the preclinical development of precision cancer therapies

Evonetix expands facilities and relocates to central Cambridge, UK Evonetix expands facilities and relocates to central Cambridge, UK

15,000 sq. ft of laboratory and office space at Coldham’s Business Park will enable continued growth and development of the Company’s integrated desktop platform for DNA synthesis

Winners of the 2019 President’s Startup Challenge Announced, as The Pistoia Alliance Looks to the Future Winners of the 2019 President’s Startup Challenge Announced, as The Pistoia Alliance Looks to the Future

Innovative startups recognised at Alliance’s annual conference, where themes included the Lab of the Future, AI, and Real-World Data